| Literature DB >> 35958258 |
Xuan Yue1, Zhejie Chen2, Jinming Zhang1, Chi Huang1, Shiyi Zhao1, Xuebo Li1, Yan Qu1, Chen Zhang1.
Abstract
Dimocarpus longan Lour. (also called as longan) is a subtropical and tropical evergreen tree belonging to the Sapindaceae family and is widely distributed in China, Southeast Asia and South Asia. The pulp of longan fruit is a time-honored traditional medicinal and edible raw material in China and some Asian countries. With the advancement of food therapy in modern medicine, longan fruit pulp as an edible medicinal material is expected to usher in its rapid development as a functional nutrient. As one of the main constituents of longan fruit pulp, longan fruit pulp polysaccharides (LPs) play an indispensable role in longan fruit pulp-based functional utilization. This review aims to outline the extraction and purification methods, structural characteristics and biological activities (such as immunoregulatory, anti-tumor, prebiotic, anti-oxidant, anti-inflammatory and inhibition of AChE activity) of LPs. Besides, the structure-activity relationship, application prospect and patent application of LPs were analyzed and summarized. Through the systematic summary, this review attempts to provide a theoretical basis for further research of LPs, and promote the industrial development of this class of polysaccharides.Entities:
Keywords: antitumor; bioactivities; extraction; immune regulation; longan fruit pulp polysaccharide; structures
Year: 2022 PMID: 35958258 PMCID: PMC9358249 DOI: 10.3389/fnut.2022.914679
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Botanical characteristics and the distribution of longan in the world. (A) The plant of longan, (B) the fruit of longan, and (C) different parts of longan fruit. (D) The approximate distribution of longan in the world (Data from the Global Biodiversity Information Facility, color figure can be viewed at wileyonlinelibrary.com).
Figure 2Schematic diagram of extraction, purification, basic structure, structural modification, biological activity and patent statistics of LPs.
The extraction, purification, and structural characterization of polysaccharides from the longan fruit pulp.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| 1 | LPS1 | Hot water | Gel filtration and anion-exchange chromatography | Glc (Consists of 661 glucose residues) | 1.08 ×105 | (1 → 6)-α-D-glucan | Immunomodulatory and anti-cancer | ( |
| 2 | LP-H | Hot water | Sevage | Rha:Ara:Man:Glc:Gal = 1.2:4.6:1:3:2.2 | 2.38 ×105 | Mainly consisted of → 3)- | Prebiotic | ( |
| 3 | LP-S | Superfine grinding | Rha:Ara:Man:Glc:Gal = 1.2:4.9:1:2.1:4 | 2.28 ×105 | Mainly consisted of → 3)- | Prebiotic | ||
| 4 | LP-SE | Superfine grinding-assisted enzymatic | Rha:Ara:Man:Glc:Gal = 1.1:4.3:1:1.5:2.8 | 1.90 ×105 | Mainly consisted of → 3)- | With better prebiotic | ||
| 5 | LP-UE | Ultra-high pressure-assisted enzyme | Sevage | Rha:Ara:Xyl:Man:Glc:Gal = 5.8:40.8:1:2.3:32.5:26.7 | 2.91 ×105 | β-type glycosidic bond | Moderate acetylcholinesterase inhibitory | ( |
| 6 | LP-H | Hot water | Rha:Ara:Xyl:Man:Glc:Gal = 1.1:11.9:1:1.6:12.2:11.1 | 1.19 ×105 | Slight acetylcholinesterase inhibitory | |||
| 7 | LP-U | Ultra-high pressure | Rha:Ara:Xyl:Man:Glc:Gal = 1.2:11.7:1.2:1:10:12.4 | 1.32 ×105 | ||||
| 8 | LP-E | Enzymatic method | Rha:Ara:Xyl:Man:Glc:Gal = 5.9:46.2:1:6:22.2:33.7 | 3.18 ×105 | ||||
| 9 | LP | Unfermented, hot water | Sevage | Rha:Ara:Xyl:Man:Glc:Gal = 5.7:28.5:1:1.5:15.3:13.3 | 2.22 ×105 | Mainly consisted of α-type and β-type glycosidic bond | Immunomodulatory and prebiotic | ( |
| 10 | LP-F | After fermentation, hot water | Sevage | Rha:Ara:Xyl:Man:Glc:Gal = 5.1:26.5:1:1.8:7.8:12.4 | 1.11 ×105 | Stronger immunomodulatory and prebiotic | ||
| 11 | LPs | Water extraction, alcohol precipitation | Gel filtration chromatography | Man:Rib:Rha:GlcA:GalA:Glu:Gal = 4:1.25:3.75:3:1:25:5.25 | (2.13–7.07) ×103 | N/A | Immunostimulatory and free radical scavenging | ( |
| 12 | MLPs | Water extraction, alcohol precipitation | Gel filtration chromatography | Man:Rib:Rha:GlcA:GalA:Glu:Gal = 19:1:17:13:3:100:24 | 2.78 ×104-1.00 ×106 | Possess more branched structures | Stronger free radical scavenging abilities and immune-stimulating effects, but weaker growth-inhibitory activities against cancer cells | |
| 13 | LP1 | Hot water | Sevage, chromatography of DEAE-cellulose and Sephadex G-100 | N/A | 1.23 ×103 | N/A | Immunomodulatory and anti-tumor | ( |
| 14 | LP1-S | Hot water | Sevage, chromatography of DEAE-cellulose and Sephadex G-100 | N/A | 1.05 ×105 | N/A | Immunomodulatory and stronger anti-tumor | |
| 15 | LPIIa | Ultrahigh pressure-assisted enzymatic | HiPrep 26/60 Sephacryl S-300 HR column | Rib:Ara:Xyl:Glc:Gal = 1.05:1:22.88:1.01:2.59:34.58 | 1.59 ×105 | The backbone consisted of (1 → 3,4)-α-Rha | Anti-inflammatory and protective intestinal barrier function | ( |
| 16 | LP3 | After extraction with distilled water, cellulase enzymolysis and ultrasonic cell disintegration were used. | Anion exchange resin D301-F | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 4.85:1.06:14.55:1.00:28.36:70.89:8.58 | N/A | N/A | Strong immunoregulatory | ( |
| 17 | LPP | N/A | Sephadex G-100 gel column and gel filtration chromatogram | N/A | 3.75 ×104 | N/A | The combination of FITC pre-labeling and HPSEC-FD makes the quantitative determination of LPP possible in mouse plasma, spleen and lung samples | ( |
| 18 | LPPF | N/A | Sephadex G-100 gel column and gel filtration chromatography | N/A | 3.9 ×104 | N/A | ||
| 19 | LPI | N/A | DEAE-cellulose anion-exchange chromatography | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 0.57:0.01:1.00:0.20:9.64:21.84:0.73 | 1.459 ×104 | Mainly consisted of (1 → 6)- | Except for LPI, the other three significantly stimulated lymphocyte proliferation in the dose range of 100–400 μg/mL and their stimulations on normal/LPS-induced proliferation and depressions on ConA-Induced proliferation could be ordered as LPIII > LPIV > LPII > LPI. All the fractions had the optimal dose of 100 μg/mL on enhancing macrophage phagocytosis. Among them, LPII had the considerable yield and activity for exploiting as a potential immunoadjuvant | ( |
| 20 | LPII | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 1.00:0.22:3.00:0.21:5.85:14.62:1.77 | 6.834 ×104 | Mainly consisted of (1 → 6)- | ||||
| 21 | LPIII | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 1.00:3.21:4.70:0.56:0.41:0.66:2.18 | 1.074 ×105 | Mainly consisted of (1 → 4)- | ||||
| 22 | LPIV | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 7.52:7.58:7.69:7.82:9.59:9.70:9.91 | 5.282 ×106 | N/A | ||||
| 23 | LPD2 | Hot water | Weak anion exchanger | Ara:Ma:Glc:Gal = 0.25:0.49:1:0.5 | 9.64 ×106 | The main linkages of the sugar residues were (1 → 4)-β-Glc and (1 → 6)-β-Man | Significantly enhanced the lymphocytes proliferation, phagocytosis and NO and IL-6 secretion by macrophage | ( |
| 24 | LPIa | Hot water | Sevage, DEAE-Sepharose Fast Flow chromatography and HiPrep 26/60 Sephacryl S-300 HR chromatography | Rha:Rib:Fuc:Ara:Xyl:Man:Glc:Gal = 0.99:1.37:34.61:1.48:1.73:5.86:55.16 | 1.47 ×105 | Mainly consisted of → 3)-α-Ara | Both LPIa and LPIIa have higher intestinal barrier protection and immunoregulatory activities than LPIIIa and LPIVa | ( |
| 25 | LPIIa | Rha:Rib:Ara:Xyl:Glc:Gal = 1.05:1.00:22.88:1.01:2.59:34.58 | 1.593 ×105 | Mainly consisted of → 3)-α-Ara | ||||
| 26 | LPIIIa | Rha:Rib:Fuc:Ara:Man:Glc:Gal = 14.46:1.85:2.31:46.17:1.00:1.97:20.99 | 1.94 ×104 | Mainly consisted of → 3)-α-Ara | ||||
| 27 | LPIVa | Rha:Rib:Ara:Man:Glc:Gal = 4.71:0.38:25.03:1.00:2.53:15.50 | 4.4 ×104 | Mainly consisted of → 3)-α-Ara | ||||
| 28 | LPPMs | Alkali-extraction and acid-precipitation | N/A | N/A | N/A | N/A | Anti-oxidation, anti-tumor and immune stimulation activity were enhanced | ( |
| 29 | LP1 | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 6.1:4.9:52.2:1:11.1:72.2:20.3 | N/A | The immunoregulatory activity was weaker than that of LP2 and LP3 | ( | |||
| 30 | LP2 | Ultrasound-assisted enzymatic method | Gel column chromatograms | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 2:1:16.7:23.7:57.2:114.3:2.2 | >105 | Mainly composed of glucosyl residues in the α-pyranose form | Immunoregulatory activity | |
| 31 | LP3 | Rib:Rha:Ara:Xyl:Man:Glc:Gal = 11.7:1:33.3:4.7:213.3:472:13.3 | Immunoregulatory activity | |||||
| 32 | LP1 | Hot water extraction and alcohol precipitation | DEAE-cellulose anion-exchange and Sephacryl S-300 HR gel chromatography | Glc:GalA:Ara:Gal = 5.39:1.04:0.74:0.21 | 1.16 ×102 | Consisted of a backbone of → 4)- | Natural anti-tumor agent with immunomodulatory activity | ( |
| 33 | LPIIa | Hot water | Ion exchange chromatography, gel filtration chromatography | Glc:Ara:Man:Gal = 7.55:1.45:1.22:1.00 | 4.47 ×104 | Mainly composed of → 6)-Glc-(1 →, → 5)-Ara-(1 →, → 4)-Man-(1 → and → 6)-Gal-(1 → | Strong immunoregulatory | ( |
| 34 | LPS-N | Hot water-assisted microwave pretreatment and ethanol precipitation method | DEAE- Cellulose anion exchange chromatography | Xyl:Glc = 1:1.9 | 1.38 ×104 | Belong to β-type heteropolysaccharide with pyran group | N/A | ( |
| 35 | LPS-A1 | Rha:Xyl:Ara:Gal = 1:1.64:4.33:2.28 | 1.382 ×103 | |||||
| 36 | LPS-A2 | Only Rha | 5.71 ×105 | |||||
| 37 | LWP | Longan juice ferments | Ultrafiltration | Glc:Man:Gal:Ara:GalA: GlcA = 167.72:3.38:3.13:3.46:2.33:1 | (1–3) ×104 | Mainly composed of β-type | Hypoglycemic activity and free radical scavenging | ( |
| 38 | LPsx | Hot water extraction and alcohol Precipitation | HPGPC system coupled with Ultrahydragel columns 500 and 250 gel columns at 60°C | Glu:Ara:Gal:Man:Xyl = 95.9:2.1:1.0:0.6:0.4 | 4.102 ×103 | Mainly composed of (1 → 6)- | The immunomodulatory activity study showed that LPsx significantly increased the phagocytosis of macrophages, and strongly promoted the production of NO, IL-1β, IL-6 and TNF-α. Moreover, LPsx could inhibit the inflammatory response induced by lipopolysaccharide. | ( |
Figure 3The structures of longan pulp polysaccharides. (A) LPS1, (B) LPIIa, and (C) LP1.
The modification approaches, containing reaction conditions, reaction principles and typical structures of modification products for different structural modifications.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| 1 | Sulfated modification | Concentrated sulfuric acid method - using the principle of sulfuric acid esterification reaction, concentrated sulfuric acid de-hydroxylation, alcohol de-hydrogenation in polysaccharides for the reaction, the introduction of sulfuric acid groups in polysaccharides, its reversible reaction. | Briefly, the mixture of concentrated sulfuric acid and butanol complex (3:1) was prepared in ice bath. Then, 125 mg ammonium sulfate was added and stirred for 10 min at temperature 0 °C (ice-water bath). LP1 (500 mg) was then dripped in slowly. The reaction mixture was stirred for 3 h at 10°C and was then neutralized with sodium hydroxide solution and precipitated with 95% ethanol. The sediment was redissolved with water, followed by dialysis, and freeze-dried. | Barium sulfate turbidimetry method | LP1-S LYRP4 | ( |
| 2 | Carboxymethylated modification | Sodium hydroxide-monochloroacetic acid (MCA) method - Introduction of carboxymethyl group on the -OH of polysaccharide by this substitution reaction system. | Dissolve LPs in alkaline solution, add a certain concentration of monochloroacetic acid (MCA), react for a period of time at a specific temperature, then dialyze the reaction solution after adjusting it to neutral, and the solution is concentrated, alcoholic precipitation, and vacuum dried. | UV spectrophotometry | CM-LYP CM-LYP2 | ( |
| 3 | Enzymatic modification | Enzymatic reaction -Certain structures can be recognized for catalytic degradation/cleavage. | Firstly, the appropriate enzyme was selected and its optimal reaction temperature and pH were determined; then a certain amount of longan fruit pulp was reacted in the vessel for a period of time and the treated sample was heated in a 90°C water bath for 3 min immediately after the reaction to stop the enzyme reaction. Finally, extraction or collection was performed. | The content of water-soluble polysaccharides was determined using the phenol-sulfuric acid colorimetry (Glucose was used as the standard). | Fructo-oligosaccharides (Fos) such as 1-kestose and nystose | ( |
| Quantitative analysis of ethanol-soluble sugars using HPLC. | ||||||
| 4 | Maillard reaction modification | Carbonyl ammonia reaction - based on the reduction between the carbonyl group of the sugar and the amino group of the amino compound. | LPs and amino acids were dissolved together in 100 mL NaOH solution (pH 9.0) to the final concentration of 2.5 mg/mL. Ten milliliters of the solution were added into a 25 mL penicillin bottle and sealed. The bottles were placed in a 100°C water bath for 1–6 h, and then transferred to an ice-water bath to end the MR between LPs and amino acids. | The browning degree was determined by the 420 nm absorbance; the Mw distribution was analyzed by a high-performance size exclusion chromatography (HPSEC) method. | MLPs (LPs-Lys) | ( |
| 5 | Microbial fermentation modification | Enzymatic reactions - Lactic acid bacteria or other microorganisms can affect polysaccharide composition by secreting different carbohydrate enzymes. These enzymes can degrade the insoluble pectocellulosic cell wall of fruit into soluble polysaccharides, resulting in increased yield of water-soluble polysaccharides as well as changes to Mw and monosaccharide composition of the extracted polysaccharides. | Fermentation experiments were conducted in aluminum foil sealed Erlenmeyer flasks, each containing 100 mL of pasteurized longan juice without any supplementary nutrients. Inoculum (1 mL) containing 7.0 log cfu/mL of activated | Neutral polysaccharide content was determined using the phenol-sulfuric acid method (Glucose was used as the standard). | LP-F ( | ( |
| Uronic acid content was determined using a modified m-hydroxydiphenyl method with galacturonic acid standards. | ||||||
| 6 Others | Alkali dissociation | Depolymerization reaction - sodium hydroxide could depolymerize polysaccharides with compact and high-organized conformation, to obtain its derivatives. Their activity could be enhanced by increasing chain stiffness | 50 mg LPI was dissolved in 50 mL distilled water, then 50 mL of NaOH solution was added and the pH was neutralized with 5 mol/L hydrochloric acid solution after alkaline dissociation at room temperature for 10 min. The mixture was dialyzed, concentrated and lyophilized. | The molecular conformations were examined by size exclusion chromatography combined with multi-angle laser light scattering (SEC-MALLS), Congo red test and atomic force microscopy (AFM). | LPI1 and LPI2 | ( |
| Phosphorylation modification | Esterification reaction - Phosphorylation modification of LPs using POCl3 (phosphorus oxychloride) as an esterifying agent | The dissolved LPs solution was slowly added to the POCl3-pyridine mixture for 60 min (kept in a reaction bath at 0°C or in an ice-water mixture environment), and at the end of the reaction, the appropriate amount of sodium hydroxide solution was added to adjust to neutral. Finally, dialysis, alcohol precipitation and drying under reduced pressure were performed. | Phosphomolybdate blue spectrophotometric determination | LYP2-P | ( | |
| Acetylation modification | Acetic anhydride method - Acetylation modification is the addition of acetyl groups to the branched chains of polysaccharides, so that the branched chains of polysaccharides are fully unfolded, exposing more sugar hydroxyl or carboxyl groups inherent in the sugar, thus improving its water solubility and more conducive to activity | The pH of the reaction system was always maintained in the range of 8.0–10.0 by adding sodium hydroxide solution and acetic anhydride alternately under certain temperature conditions until the acetic anhydride was added, and the reaction was adjusted to neutral with hydrochloric acid solution after stirring for a period of time. Finally, dialysis, concentration, alcohol precipitation and freeze-drying were performed. | Hydroxylamine colorimetric assay | Ac-LYP2 | ( | |
Figure 4The activation of macrophages and the enhancement of phagocytic function are indicators of the enhancement of LPs immunomodulation, anti-tumor and anti-inflammatory activities. (A) The comparison of phagocytosis indexes of LPI–IV at 100 or 200 μg/mL. (B) The phagocytosis indexes of LPI-IV in the dose range of 100–400 μg/mL (34). (C) Possible molecular mechanism of LPs activating macrophages (35).
Figure 5LP regulated systemic and intestinal immunity (89). (1) Systemic immunity: LP increased spleen and thymus indexes and serum IgA level. (2) Intestinal immunity: LP regulated intestinal microbiota composition via utilization by partial commensal bacteria; LP promoted the migration and gut homing of IgA+ plasma cells; LP directly stimulated transcytosis of dIgA-pIgR and pIgR.
Figure 6The analysis of 630 patents browsed was obtained by Lens.org using the search term “Longan polysaccharide.” (A) Patent applications per years, (B) Document type, (C) Jurisdictions, and (D) CPC Classification.